Matthias Alder, CEO of Gain Therapeutics GANX, has filed 0 purchases and 2 sales on the open market. The latest trade was on 24/03/26.

MA

MA

Matthias Alder

CEO

Company

Gain Therapeutics GANX

First filing

23/03/27

Trades

20 trades

Buys / sales

0 / 2

12-month net buying

No record

Last trade

24/03/26

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Gain TherapeuticsGANX	Open-market sale	23/12/21	23/12/22	206 sh	$2.46	$506.76	−3.8%
Gain TherapeuticsGANX	Open-market sale	23/12/07	23/12/14	1,820 sh	$2.50	$4,550	−27.3%